MediPharm Labs Launches LABS Cannabis CBD Isolate In Canada

By RTTNews Staff Writer   ✉   | Published:

MediPharm Labs Corp., a Canada-based provider of cannabis oil and concentrates, said it has launched LABS Cannabis CBD Isolate in Canada. The product, the first of its kind in Canada, is also the company's first in its LABS Cannabis branded product line.

According to MediPharm Labs, the product is designed for Canadians seeking a THC-free experience. The 99 percent pure CBD crystalline isolate will be available to consumers through retailers across Canada.

Cannabidiol or CBD is a naturally occurring cannabinoid constituent of cannabis. It is a chemical in the marijuana plant often used for medicinal purposes, and does not have the intoxicating effects like those caused by tetrahydrocannabinol or THC.

"Produced at commercial scale, LABS Cannabis CBD Isolate has only trace amounts of THC - less than 0.2% - which makes it an excellent choice for a broad range of wellness consumers and patients seeking the potential benefits of CBD without the intoxicating effects of THC," said Pat McCutcheon, CEO of MediPharm Labs.

Pure CBD crystalline isolate is a fine-white crystalline powder with 99 percent pure CBD in a concentrated form. The all-natural cannabinoid product is made from cannabis extract refined through numerous steps. Each container of LABS Cannabis CBD Isolate contains 500mg of product in powder form, MediPharm Labs noted.

As CBD crystalline isolate does not have intoxicating effects, and is almost flavorless and odorless, it can be taken daily and consumed in different ways by new or experienced wellness consumers.

In early October, MediPharm Labs said that German pharmaceutical company STADA Arzneimittel AG signed an exclusive medical cannabis supply agreement with a wholly owned subsidiary of MediPharm. The partnership signaled MediPharm's entry into the global pharmaceutical industry within a major European market.

MediPharm Labs said in September that it is entering Brazil in partnership with XLR8 Brazil, a Rio de Janeiro-based distributor for medical cannabis products. Brazil is Latin America's largest medical cannabis market.

For comments and feedback contact: editorial@rttnews.com

Business News

Next Story
Editors Pick
Volkswagen Stock Up On Higher Sept. Deliveries, Q3 Market Recovery; Backs FY20 View
Shares of Volkswagen Group were gaining around 3 percent in German trading after the automotive giant Thursday reported market recovery in the third quarter with improved deliveries in the month of September. For the first nine months of fiscal 2020, the company, meanwhile reported sharply lower earnings with weak revenues and sales volume.
Comcast Q3 Profit Declines 37%, But Results Top Estimates
Comcast Corp. on Thursday reported a 37 percent decline in profit for the third quarter from last year, hurt primarily by revenue decline at NBCUniversal. Both adjusted earnings per share and quarterly revenues topped analysts' expectations. The company also declared a quarterly dividend. In the pre-market trade, CMCSA is trading at $42.83, up $0.85 or 2.02 percent.
Regeneron Says Its Covid-19 Outpatient Therapy Could Reduce Virus Levels
Regeneron announced positive results from its late stage COVID-19 outpatient trial, indicating that its antibody cocktail therapy significantly reduced virus levels and need for further medical attention. The trial results showed that investigational antibody cocktail, REGN-COV2, met the primary and key secondary endpoints.